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Abstract
Background: Anxiety and depression are common after heart transplantation. This study aimed to pilot test the
feasibility of a clinical model of psychological care for heart transplant recipients. The model of care involved
nurse-led screening for anxiety and depression followed by referral for a course of telephone-delivered cognitive
behaviour therapy as well as co-ordination of communication with on-going specialist and primary care services.
Methods: A pilot randomised controlled trial was conducted. Heart transplant recipients who self-reported at least
mild anxiety or depressive symptoms were randomised (defined as a score higher than 5 on the Patient Health
Questionnaire-9 or the Generalized Anxiety Disorder-7 [GAD-7], or a score higher than 20 on the Kessler
Psychological Distress Scale [K10]). The primary outcome was assessment of feasibility of conducting a larger trial,
which included identification of recruitment and attrition rates as well as the acceptability of the intervention.
Follow-up was conducted at 9 weeks and 6 months.
Results: One hundred twenty-two of the 126 (97 %) heart transplant recipients assessed on their attendance at
the outpatient clinic met the study eligibility criteria. Of these patients, 88 (72 %) agreed to participate. A
moderate proportion of participants (n = 20; 23 %) reported at least mild symptoms of anxiety or depression.
Five participants were excluded because they were currently receiving psychological counselling, two withdrew
before randomisation and the remaining 13 were randomised (seven to intervention and six to usual care). The
majority of the randomised participants were male (n = 9; 69 %) and aged over 60 (range 35–73). Median length
of time post-transplant was 9.5 years (ranging from 1 to 19 years). On enrolment, 3 randomised participants
were taking anti-depressants. One intervention group participant withdrew and a further 3 (50 %) declined the
telephone-delivered CBT sessions; all because of restrictions associated with physical illnesses. Attrition was 30 %
at the 6 month follow-up time-point.
Conclusions: Due to the poor acceptability of telephone-delivered cognitive behavioural therapy observed in our
sample, changes to intervention components are indicated and further pilot testing is required.
Trial registration: ACTRN12613000740796 Date registered: 03/07/2013.
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Background
The International Society for Heart and Lung Transplant-
ation has recommended studies should be conducted to
identify interventions that will maximize psychological
outcomes after heart transplantation [1]. The society
further suggested that intervention studies adapt interven-
tions that have previously demonstrated effectiveness in
improving psychological outcomes for patients with other
chronic diseases relevant to the heart transplant popula-
tion. One example of an effective intervention is cognitive
behaviour therapy.
Cognitive behaviour therapy (CBT) is a form of psy-
chotherapy, in which therapists help patients overcome
psychological symptoms by changing their thinking, be-
haviour and emotional responses [2]. CBT has proven
very effective in the treatment of depression and anxiety,
in general, as well as for patients with cardiovascular
disease specifically [3]. A recent meta-analysis reported
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that psychological intervention resulted in moderate
improvements in depression and anxiety in patients with
coronary heart disease [4]. Also of note, the largest
randomised controlled trial of CBT in patients with
cardiovascular disease, which randomised 2481 patients
post-myocardial infarction, reported that the improvement
in psychosocial outcomes at 6 months favoured the group
that received counselling (mean [SD] change −10.1 [7.8] vs.
-8.4 [7.7]; p < 0.01) [5]. This evidence suggests that CBT is
likely to decrease anxiety and depression symptoms for
heart transplant recipients and therefore should be consid-
ered for formal evaluation in a controlled trial.
The ISHLT also recommends: that each heart trans-
plant team should include a psychologist because multi-
disciplinary treatment teams are better prepared to
address psychosocial risk factors for poor outcomes after
heart transplantation; that depressive symptoms should
be regularly evaluated during follow-up of heart trans-
plant recipients using validated screening instruments;
and that all patients who screen positive for symptoms
of depression should be referred for specialized treat-
ment [6]. It should be noted, though, that these recom-
mendations are based on consensus. High level evidence
demonstrating the benefit of these interventions on
heart transplant recipient outcomes is required. For this
reason, it was decided to pilot test the feasibility of a
model of care that operationalizes these recommenda-
tions with the view towards conducting a larger clinical
trial. The key features of the model of care that align
with the ISHLT recommendations pilot tested in the
study reported in this paper include:
 Screening for psychological symptoms;
 Referral for specialized treatment (CBT) for patients
with elevated psychological symptoms; and
 Involvement of a multidisciplinary team, including
nurses, psychologists, heart transplant physicians
and General Practitioner/Primary care providers.
Methods
A pilot randomised controlled trial was conducted. Human
research ethics committee and institutional approval was
granted for the study (HREC13QPCH239; 1300000686). It
was registered prospectively with the Australian New
Zealand Clinical Trials Registry (ACTRN12613000740796).
Outcomes
The primary outcome of this study was the feasibility of
conducting a larger clinical trial. Assessment of feasibility
included recruitment issues, likely attrition rates and ac-
ceptability of interventions, which are important consi-
derations in planning a larger clinical trial. A planned
secondary outcome was to evaluate the potential efficacy
of the intervention.
Participants
Heart transplant recipients aged over 18 years who were
scheduled for a routine outpatient consultation with the
Heart Transplant Nurse Practitioner at a major metro-
politan hospital in Australia were eligible to participate
in the study. Patients less than 3 months post-transplant
as well as those who were cognitively impaired (as
confirmed by a treating clinician), unable to understand
and speak English, had a diagnosed major psychiatric
comorbidity (schizophrenia, bipolar, dementia) or had a
terminal illness (such as cancer) were excluded. Partici-
pants who reported at least mild symptoms of anxiety,
depression or psychological distress but who were not
currently receiving regular psychological therapy from a
mental health practitioner were randomised to interven-
tion or control groups.
Procedure
Prior to their consultation with the Nurse Practitioner, con-
senting participants completed questionnaires to measure
the severity of symptoms commonly associated with anxiety
and depression (Patient Health Questionnaire-9 [PHQ-9],
Generalized Anxiety Disorder-7 [GAD-7], Kessler Psycho-
logical Distress Scale [K10]) as well as questionnaires to
evaluate quality of life (Short Form-36 [SF-36]), transplant-
specific self-care (Transplant Care Index [TCI], immu-
nosuppression adherence (Basel Assessment of Adherence
to Immunosuppressive Medications Scale [BAASIS])
and symptom occurrence and distress (Modified Tra-
nsplant Symptom Occurrence and Symptom Distress
Scale [MTSOSD-R]). The PHQ-9, GAD-7 and K10
results were made available to the Nurse Practitioner
during the clinic visit so that usual clinical advice and
referrals for patients experiencing psychological distress
could be actioned. Participants with scores over 5 on
the GAD-7 or PHQ-9 or scores over 20 on the K10 (in-
dicating at least mild anxiety or depressive symptoms)
were randomised to the intervention or control group.
Intervention
All randomised participants received usual care, which
involved receiving routine clinical advice from the Heart
Transplant Nurse Practitioner for patients identified as
experiencing psychological distress as well as a letter to
the participant’s General Practitioner advising them of
the severity of psychological symptoms and their partici-
pation in the study.
Participants randomised to the intervention group
were also offered:
 eight telephone-delivered CBT sessions, of about
60 min, delivered by a Doctor of Clinical Psychology
student (under the supervision of an accredited
Clinical Psychologist); followed by.
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 a multidisciplinary case conference between the
Heart Transplant Nurse Practitioner, psychologist
and the participant’s General Practitioner
regarding the implications for on-going
psychological care in light of the participant’s
response to the course of CBT.
The CBT sessions followed the format recommended
by Beck, which involved identifying automatic negative
thoughts and practicing reframing techniques, problem-
solving, coping strategies and relapse prevention [7].
Participants were encouraged to perform these tasks in
the time between their counselling sessions in order to
reinforce learnt skills. As medical-surgical recovery was
not a focus of the intervention, any questions or con-
cerns related to the clinical aspects of heart transplant-
ation that arose during CBT sessions were to be directed
to the Heart Transplant Nurse Practitioner.
Following the course of CBT, the participant’s General
Practitioner and members from the Heart Transplant
team including the Nurse Practitioner were invited to
participate in a case conference. The objective of the
case conference was to discuss the patient’s case, their
current symptoms, problems they will face and how the
problems and symptoms can be managed, with particu-
lar attention paid to identifying who will be responsible
for particular courses of action. The psychology student
who performed the counselling as well as the clinical
supervisor for the student were required to attend the
conference. Written summaries of the case conferences
were to be provided to the participant and each partici-
pating health care provider.
Data collection
Demographics and clinical characteristics, including current
medical therapy, were collected from medical records.
Psychological symptom experience, quality of life and im-
munosuppression treatment adherence data were measured
using self-report questionnaires. Questionnaires were com-
pleted by participants at the outpatient clinic. Follow-up
with each randomised participant was conducted by a
Research Assistant, who was a Registered Nurse, blinded to
treatment allocation at 9 weeks 6 months following
baseline assessment. Questionnaires were administered
by telephone. At each follow-up data collection point,
the research assistant attempted to call the patient
over a period of 1 week, with up to four phone calls
on different days and at different times of day.
Measures
Patient health questionnaire 9-item scale
The Patient Health Questionnaire 9-item scale (PHQ-9)
is a brief self-report measure of depression [8]. Partici-
pants were asked to consider the preceding 2 weeks and
rate symptom frequency as not at all (0), several days
(1), more than half of all days (2) or nearly all days (3).
Cut points of 5, 10, and 15 representing mild, moderate,
and severe levels of depression have been defined for
this instrument [8].
Generalized anxiety disorder 7-item scale
The Generalized Anxiety Disorder 7-item scale (GAD-7) is
a self-reported measure of anxiety. Higher scores indicate
higher levels of anxiety. Participants were asked to consider
the preceding 2 weeks and rate symptom frequency as not
at all (0), several days (1), more than half of all days (2) or
nearly all days (3). A recent validation study of identified
that internal consistency was high (α = 0.92) and that
it was strongly correlated with the Beck Anxiety In-
ventory (Spearman’s correlation coefficient = 0.72) [9]. Cut
points of 5, 10, and 15 representing mild, moderate, and se-
vere levels of anxiety have been defined for the GAD-7 [9].
Kessler psychological distress scale (K-10)
The Kessler Psychological Distress Scale (K-10) mea-
sures psychological distress. It is used frequently in
research and clinical practice to screen for psychological
disorders. The 10 items measure severity of anxiety and
depression symptoms using a 5-point Likert type scale.
The K-10 strongly discriminates between community
cases and non-cases of DSM-IV psychological disorders
[10]. A cut-off score of 20 had a sensitivity of 0.66 and
specificity of 0.92 for detecting a current anxiety or
affective disorder in a population-based survey [11].
Medical outcomes short form-36 health survey
The Medical Outcomes Short Form-36 Health Survey
(SF-36) yields an 8-scale profile of self-reported functional
health and well-being. Higher scores indicate a better
health status [12]. The domains of quality of life measured
by the SF-36 are physical functioning, role limitations due
to physical health, role limitations due to emotional prob-
lems, energy/fatigue, emotional well-being, social func-
tioning, pain and general health.
Basel assessment of adherence to immunosuppressive
medications scale
The Basel Assessment of Adherence to Immunosuppres-
sive Medications Scale (BAASIS) consists of 4 items that
measure the ingestion and timing of medications, drug
holidays and dose reductions. Non-adherence can be
defined as non-adherence on any of the 4 items [13].
The BAASIS also assesses overall adherence using a
visual analogue scale (VAS) scale ranging from 0 (never
took medications as prescribed) to 100 (always took
medications as prescribed). This instrument has sensitiv-
ity of 87.5 % and specificity of 78.6 % compared to
prospective 1-year virologic failure [14, 15].
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Transplant care index
The Transplant Care Index (TCI) consists of 6 items
rating difficulty in self-care, specifically in relation to
transplant-related factors such as attending scheduled
health care consultations, following recommended pat-
terns of nutrition and exercise, having scheduled pa-
thology tests, adhering to the prescribed medication
regimen and dealing with medication side effects. This
instrument demonstrated acceptable internal consistency
(Cronbach’s alpha 0.76–0.82) in a sample of 598 renal
transplant recipients [16].
Modified transplant symptom occurrence and symptom
distress-revised
The Modified Transplant Symptom Occurrence and
Symptom Distress-Revised (MTSOSD-R) was devel-
oped to assess occurrence and distress experienced by
the side effects of immunosuppression medications.
Content validity, construct validity and discriminant
validity of the instrument were substantiated in a
study of 108 renal transplant recipients [17, 18]. A
subsequent study undertaken with 216 heart transplant
recipients demonstrated the internal consistency of
this scale. Internal consistency was high for the symp-
tom occurrence (.947) and symptom distress (.984)
subscales [19].
Allocation sequence generation and concealment method
A computer generated table of random sequence
was used to randomly allocate participants to one
of two conditions (intervention/control). Sealed, se-
quentially numbered envelopes concealed the ran-
domisation sequence.
Statistical analysis
Descriptive statistics were used to assess recruitment
rates, intervention acceptability and attrition. As per
our protocol, it was intended to randomise 30 pa-
tients to intervention or control groups in this study
because it was expected that this sample would have
been sufficient to provide preliminary data to under-
stand the feasibility of the intervention and determine
effect size for sample size estimation to adequately
power a future larger clinical trial. However, due to
the smaller than anticipated number of recruited par-
ticipants and high proportion of participants rando-
mised to the intervention group not completing the
protocol, we could not perform these planned ana-
lyses. Descriptive statistics were calculated to describe
the characteristics of participants in the study at base-
line. Changes in psychological symptom severity from
baseline to follow-up were calculated for individual
participants but not compared between the interven-
tion and control groups.
Results
Recruitment
A CONSORT flowchart is presented in Fig. 1. From January
to September 2014, 122 of the 126 (97 %) heart transplant
recipients assessed on their attendance at the outpatient
clinic met the study eligibility criteria. Of these patients, 88
(72 %) agreed to participate. A moderate proportion of
participants (n = 20; 23 %) reported at least mild symptoms
of anxiety or depression. Five of these participants were
excluded because they were currently receiving psycho-
logical counselling, two withdrew before randomisation and
the remaining 13 were randomised.
Participant characteristics at baseline
An overview of demographic and clinical characteristics
of the intervention and control groups is presented in
Table 1. The majority of the randomised participants
were male (n = 9; 69 %) and aged over 60 (range 35–73).
Median length of time post-transplant was 9.5 years
(ranging from 1 to 19 years). On enrolment, 3 ran-
domised participants were taking anti-depressants. A
summary of intervention and control group participants’
health-related quality of life, immunosuppression-related
symptom prevalence and treatment adherence is pre-
sented in Table 2. Most randomised participants gener-
ally did not report difficulties with adherence with
immunosuppression therapy (Median score of 98 out of
a possible 100 on the BAASIS measure of self-reported
overall treatment adherence; Interquartile range 95–
100). The majority of the sample reported poor health-
related quality of life, with a median score of 50 of a
possible 100 for the ‘General Health’ domain of the SF-
36 (IQR 50–55).
Acceptability of intervention components
After randomisation, one participant from the interven-
tion group withdrew from the study. A further 3 (50 %)
of the intervention participants declined the telephone-
delivered CBT sessions; all because of restrictions associ-
ated with physical illness. Two intervention participants
(33 %) completed the CBT sessions. Neither of these
participants had a history of a diagnosed anxiety or
depression disorder. A case conference with one of the
intervention participant’s general practitioners could not
be scheduled at a time that suited all members of the
transplant team. The other intervention participant who
completed the course of CBT requested that the case
conference not be conducted. Written reports from the
psychologist were circulated instead.
Attrition
All participants who had not withdrawn from the study
completed the follow-up questionnaires at 9 weeks after
screening. One participant (16 %) in the intervention
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group and two participants (29 %) in the control group
were not able to be contacted for 6 month follow-up.
Changes in severity of psychological symptoms
Psychological symptoms measured with the PHQ-9
and GAD-7of the two participants (33 %) who
completed the course of CBT reduced to scores
below 5 at follow-up conducted at 9 weeks post-
screening. All intervention group participants who
declined CBT (n = 3; 67 %) still reported psycho-
logical symptoms with a score greater than 5 on the
PHQ-9 or GAD-7 at the 9 week follow-up (n = 1
withdrew after randomisation). Four (57 %) of the
seven control group participants still experienced
symptoms with a score greater than 5 on the PHQ-9
or GAD-7 at the 9 week follow-up. At 6 month
follow-up, two participants (40 %) in the control
group reported psychological symptoms with a score
greater than 5 on the PHQ-9 or GAD-7 (two partici-
pants were lost to follow-up). All participants in the
intervention group who completed the follow-up
questionnaire at 6 months after screening reported
PHQ-9 and GAD-7 scores <5 (n = 4; 1 participant
had withdrawn and one participant could not be
contacted).
Fig. 1 CONSORT Flow diagram
Table 1 Baseline demographic and clinical characteristics
Variable Intervention
n = 6
Control
n = 7
Median (range)
or Count (%)
Median (range)
or Count (%)
Age 57 (43–70) 61 (35–73)
Male 4 (67) 5 (71)
Years since transplant 9 (2–19) 10 (1–18)
Number of comorbidities 8 (3–8) 8 (7–10)
History of anxiety or depression disorder 3 (50) 1 (14)
Taking anti-depressants 1 (14) 2 (29)
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Discussion
The main finding of this pilot study is that the majority
of heart transplant recipients who reported at least mild
symptoms of anxiety or depression on screening at their
routine outpatient appointment but were not currently
receiving psychological counselling did not accept a
telephone-delivered CBT intervention. Results may re-
flect the broader difficulties in treating mental health
problems stemming from perceived risk of stigmatisa-
tion associated with being diagnosed with a psycho-
logical disorder [20]. However, participants’ decisions to
accept psychological treatment may also have been influ-
enced by the unique experiences associated with heart
transplantation. Qualitative studies have identified that
competing senses of hope and gratitude mixed with guilt
and grief regarding the acceptance of a heart from a
deceased donor may contribute to anxiety and depres-
sion in this population [21]. In this regard, a noteworthy
finding is that the acceptability of telephone-delivered
CBT was worse in our sample of heart transplant recipi-
ents compared with other chronic disease populations.
For example, the MoodCare study similarly involved a
course of telephone-delivered CBT for patients hospita-
lised with acute coronary syndrome who reported de-
pressive symptoms with a PHQ-9 score more than 5
[22]. Yet in the Mood Care study, 61 % of the 61 partici-
pants who were randomised to the intervention group
completed five or more CBT sessions and the median
number of sessions was eight [22]. It should be noted,
though, that 32 % of participants in the Mood Care
study who were eligible for inclusion based on initial
screening that took place in hospital either withdrew or
were lost to follow-up at a second screening undertaken
just prior to randomisation [22]. Future trials involving
psychological interventions for heart transplant reci-
pients should therefore consider utilising a two-stage
screening process to confirm participants’ intentions in
taking part in CBT before randomisation.
Due to the poor acceptability of telephone-delivered
CBT observed in our sample, changes to intervention
components are indicated and further pilot testing should
be conducted before proceeding to a clinical trial of a
psychological intervention for heart transplant recipients
with anxiety or depression. One change to consider pilot-
ing would be to raise the screening cut-off scores. Alo-
ngside this pilot study, we evaluated the validity and
reliability of the PHQ-9, GAD-7 and K-10 for detection of
anxiety or depression. Full details are reported elsewhere
(under review). It was identified that the optimal cut-off
score for detecting depression was a score of 10, which is
considerably higher than the score we used for eligibility
to be randomised to CBT in the pilot study. Moreover, it
is known that PHQ-9 scores may include a small amount
of variance from somatic symptoms not related to depres-
sion [23]. For these reasons, it is not surprising that some
intervention group participants declined CBT due to
physical illness. These participants may have accumulated
a PHQ-9 score >5 due to the severity of somatic symp-
toms contained within the PHQ-9 that were not nece-
ssarily caused by depression, such as fatigue and sleep
disturbance. An alternative to raising the cut-off score in
an effort to decrease false-positive screening is to conduct
a structured psychological interview with heart transplant
recipients who screen positive for a potential psycho-
logical disorder. Psychological interventions can then be
targeted at only those heart transplant recipients who
meet criteria for a psychological disorder.
Table 2 Baseline severity of psychological and
immunosuppression-related symptoms and levels of
health-related quality and treatment adherence
Variable Intervention
n = 6
Median (IQR)
Control
n = 7
Median (IQR)
PHQ-9 score 9 (7–13) 10 (8–18)
GAD-7 score 4.5 (2–7) 8 (7–10)
K-10 score 19.5 (17–21) 20 (16–25)
Difficulty with keeping scheduled
follow-up visitsd
5 (4–5) 4 (4–5)
Difficulty with following a regular
exercise programd
2.5 (1–4) 2 (1–3)
Difficulty with following a healthy
and balanced dietd
4 (2–4) 2 (2–3)
Difficulty with having tests done
as scheduledd
5 (5–5) 4 (4–5)
Difficulty with taking all medicines
as prescribedd
5 (5–5) 4 (4–5)
Difficulty with side effects
of medicinesd
4.5 (2–5) 4 (3–4)
Immunosuppression treatment
adherencea
100 (100–100) 95 (90–98)
Number of immunosuppression-related
symptoms experienced ‘almost always’
or ‘always’b
6.5 (3–12) 7 (3–12)
Physical functioningc 70 (25–95) 40 (15–55)
Role limitations due to
physical healthc
50 (0–75) 25 (0–75)
Role limitations due
to emotional problemsc
0 (0–100) 100 (0–100)
Energy/fatiguec 27.5 (5–50) 30 (20–35)
Emotional well-beingc 70 (64–72) 60 (60–64)
Social functioningc 50 (50–63) 50 (50–50)
Painc 36 (33–48) 50 (35–58)
General healthc 53 (50–55) 50 (40–50)
IQR interquartile range, aRating of overall treatment adherence over the past
2 weeks on a scale of 0–100 (higher score = better adherence); bMTSOSD-59;
cScores range from 0 to 100 with higher scores representing better health-
related quality of life’; d1 = Very difficult, 5 = Very easy; PHQ-9 = Patient Health
Questionnaire 9-item scale; GAD-7 = Generalized Anxiety Disorder 7-item scale;
K-10 = Kessler Psychological Distress Scale
Conway et al. BMC Nursing  (2016) 15:62 Page 6 of 8
A further alternative, which would be prudent to investi-
gate based on results from this pilot study that indicated a
2 month period of counselling was not acceptable to most
participants, is to consider the use of nurse-led brief inter-
ventions to improve psychological outcomes for heart
transplant recipients. A nurse-led brief CBT intervention
has been shown to be accepted well by hospitalised heart
failure patients. In a randomised controlled trial, hospita-
lised heart failure patients who reported mild-moderate
symptoms of depression as indicated by Beck Depression
Inventory scores of 10–28 were randomised to usual care
or a single, nurse-delivered, 30-min, one-on-one cognitive
therapy session that took place in a hospital followed by a
5–10 min telephone ‘booster’ that was conducted 1 week
after discharge [24]. In this study, 20 of the 21 patients
randomised to the intervention group received the allo-
cated intervention [24].
It was planned to investigate the potential efficacy of the
intervention on health-related quality of life, severity and
distress of immunosuppression-related symptoms and
treatment adherence by calculating effect sizes. However,
this was not conducted due to the smaller than anticipated
sample size. Reassuringly, both participants who received
CBT as part of the study had remission of their symptoms
after the end of the 8-week course of counselling. This is
consistent with the previous literature in other popula-
tions that has overwhelmingly demonstrated that CBT
reduces the severity of psychological symptoms and that
telephone-delivered CBT is equally as effective as a face to
face counselling strategy [25, 26].
A limitation of this pilot study to consider is that it
was conducted at only one transplantation centre. Also,
selection bias might have influenced the results. Heart
transplant recipients suffering from anxiety or depres-
sion may have been less inclined to participate in the
research [27]. Heart transplant recipients were also
screened for the presence of anxiety or depression only
once during the data collection period, even if they
attended the outpatient clinic multiple times over that
period. Potentially, screening at each attendance would
have increased detection of anxiety or depression.
Conclusions
Results from our study indicated that many heart trans-
plant recipients who might have benefited from psycho-
logical intervention did not accept treatment in the form
of telephone-delivered CBT. It is unknown whether or not
other modes of delivering CBT (face to face or online)
would be more or less acceptable. These are potential
areas to consider pursuing in further research aimed at
improving psychological outcomes for heart transplant
recipients. Due to the poor acceptability of telephone-
delivered CBT observed in our sample, changes to inter-
vention components are indicated and further pilot testing
should be conducted before proceeding to a large clinical
trial of a psychological intervention for heart transplant
recipients with anxiety or depression.
Additional files
Additional file 1: Dataset. (XLS 27 kb)
Abbreviations
BAASIS: Basel assessment of adherence to immunosuppressive medications
scale; CBT: Cognitive behavioural therapy; GAD-7: Generalized anxiety
disorder-7; IQR: Interquartile range; ISHLT: International society for heart and
lung transplantation; K10: Kessler psychological distress scale; MTSOSD-
R: Modified transplant symptom occurrence and symptom distress scale;
PHQ-9: Patient health questionnaire-9; SF-36: Medical outcomes short form
health survey-36; TCI: Transplant care index
Acknowledgements
None.
Funding
This study was conducted with funding from the Institute of Health and
Biomedical Innovation at Queensland University of Technology and the
Sigma Theta Tau International Honour Society of Nursing.
Availability of data and materials
All data generated or analysed during this study are included in this
published article [and its Additional file 1].
Authors’ contributions
AC, JS, JM, PF made substantial contributions to conception and design,
or acquisition of data, or analysis and interpretation of data; AC drafted
the manuscript; JS, JM, PF, revised critically the manuscript for important
intellectual content; AC, JS, JM, PF have given final approval of the
version to be published.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Human research ethics committee and institutional approval was
granted for the study (HREC13QPCH239; 1300000686). Participants
provided written consent.
Author details
1Institute of Health and Biomedical Innovation, Queensland University of
Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD 4059, Australia. 2School
of Psychology, Queensland University of Technology (QUT), Brisbane,
Australia. 3Advanced Heart Failure and Transplant Unit, The Prince Charles
Hospital, Chermside, Australia. 4Nursing Research and Practice Development
Centre, The Prince Charles Hospital & School of Nursing, Midwifery and
Paramedicine, Australian Catholic University, Sydney, Australia.
Received: 24 February 2016 Accepted: 12 October 2016
References
1. Cupples S, Dew MA, Grady KL, et al. Report of the Psychosocial
Outcomes Working Group of the Nursing and Social Sciences Council
of the International Society for Heart and Lung Transplantation:
Present status of research on psychosocial outcomes in cardiothoracic
transplantation: Review and recommendations from the field.
J Heart Lung Transplant. 2006;25:716–25.
2. Beck JS and Beck AT. Cognitive behavior therapy. New York: Basics and
beyond. Guilford Publication, 2011.
Conway et al. BMC Nursing  (2016) 15:62 Page 7 of 8
3. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of
cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev.
2006;26:17–31.
4. Whalley B, Thompson DR and Taylor RS. Psychological Interventions for
Coronary Heart Disease: Cochrane Systematic Review and Meta-analysis. Int
J Behav Med. 2014;21:109–121.
5. Berkman L, Burg M, Carney R, et al. Effects of treating depression and low
perceived social support on clinical events after myocardial infarction: the
enhanced recovery in coronary heart disease patients (ENRICHD)
randomized trial. J Am Med Assoc. 2003;289:3106–16.
6. Costanzo MR, Dipchand A, Starling R, et al. The International Society of
Heart and Lung Transplantation Guidelines for the care of heart transplant
recipients. J Heart Lung Transplant. 2010;29:914–56.
7. Beck AT. Cognitive therapy of depression. New York: The Guilford Press,
1979.
8. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report
version of PRIME-MD. J Am Med Assoc. 1999;282:1737–44.
9. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing
generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092.
10. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor
population prevalences and trends in non-specific psychological distress.
Psychol Med. 2002;32:959–76.
11. Andrews G, Slade T. Interpreting scores on the Kessler psychological distress
scale (K10). Aust N Z J Public Health. 2001;25:494–7.
12. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life
measurement: bibliographic study of patient assessed health outcome
measures. Br Med J. 2002;324:1417.
13. Doesch A, Mueller S, Konstandin M, et al. Increased adherence after switch
from twice daily calcineurin inhibitor based treatment to once daily
modified released tacrolimus in heart transplantation: a pre-experimental
study. Transplant Proc. 2010;42:4238–42. Elsevier.
14. Glass TR, De Geest S, Hirschel B, et al. Self-reported non-adherence to
antiretroviral therapy repeatedly assessed by two questions predicts treatment
failure in virologically suppressed patients. Antivir Ther. 2008;13:77.
15. Deschamps AE, De Geest S, Vandamme A-M, Bobbaers H, Peetermans WE,
Wijngaerden EV. Diagnostic value of different adherence measures using
electronic monitoring and virologic failure as reference standards. AIDS
Patient Care STDs. 2008;22:735–43.
16. Matas AJ, Halbert R, Barr ML, et al. Life satisfaction and adverse effects in renal
transplant recipients: a longitudinal analysis. Clin Transpl. 2002;16:113–21.
17. Moons P, De Geest S, Versteven K, et al. Psychometric Properties of the
“Modified Transplant Symptom Occurrence and Symptom Distress Scale”.
J Nurs Meas. 2001;9:115–34.
18. Dobbels F, Moons P, Abraham I, Larsen CP, Dupont L, De Geest S.
Measuring symptom experience of side‐effects of immunosuppressive
drugs: the Modified Transplant Symptom Occurrence and Distress Scale.
Transpl Int. 2008;21:764–73.
19. Stiefel P, Malehsa D, Bara C, Strueber M, Haverich A, Kugler C. Symptom
experiences in patients after heart transplantation. J Health Psychol. 2013;18:
680–92.
20. Bijl RV, Ravelli A. Psychiatric morbidity, service use, and need for care in the
general population: results of The Netherlands Mental Health Survey and
Incidence Study. Am J Public Health. 2000;90:602–7.
21. Conway A, Schadewaldt V, Clark R, Ski C, Thompson DR, Doering L. The
psychological 11 experiences of adult heart transplant recipients: a
systematic review and meta-summary of qualitative findings. Heart Lung.
2013;42:449–55.
22. O’Neil A, Taylor B, Sanderson K, et al. Efficacy and feasibility of a tele-
health intervention for acute coronary syndrome patients with
depression: Results of the “MoodCare” randomized controlled trial.
Ann Behav Med. 2014;48:163–74.
23. Leavens A, Patten SB, Hudson M, Baron M, Thombs BD. Influence of somatic
symptoms on patient health questionnaire‐9 depression scores among
patients with systemic sclerosis compared to a healthy general population
sample. Arthritis Care Res. 2012;64:1195–201.
24. Dekker RL, Moser DK, Peden AR, Lennie TA. Cognitive therapy improves
three-month outcomes in hospitalized patients with heart failure. J Card
Fail. 2012;18:10–20.
25. Muller I, Yardley L. Telephone-delivered cognitive behavioural therapy: a
systematic review and meta-analysis. J Telemed Telecare. 2011;17:177–84.
26. Mohr DC, Ho J, Duffecy J, et al. Effect of telephone-administered vs
face-to-face cognitive behavioral therapy on adherence to therapy and
depression outcomes among primary care patients: a randomized trial.
JAMA. 2012;307:2278–85.
27. Stevens T, Katona C, Manela M, Watkin V, Livingston G. Drug treatment of
older people with affective disorders in the community: lessons from an
attempted clinical trial. Int J Geriatr Psychiatry. 1999;14:467–72.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Conway et al. BMC Nursing  (2016) 15:62 Page 8 of 8
